162 related articles for article (PubMed ID: 32968870)
21. Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature.
Grebenciucova E; Reder AT; Bernard JT
Mult Scler Relat Disord; 2016 Sep; 9():158-62. PubMed ID: 27645366
[TBL] [Abstract][Full Text] [Related]
22. Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis.
Samaraweera AP; Cohen SN; Akay EM; Evangelou N
Mult Scler; 2016 Jan; 22(1):122-4. PubMed ID: 26219664
[TBL] [Abstract][Full Text] [Related]
23. Aggressive cutaneous leishmaniasis in a patient with multiple sclerosis treated with fingolimod.
Hernández Clares R; Sánchez Pedreño P; García Vazquez E; Carreón Guarnizo E; Meca Lallana JE
Neurologia (Engl Ed); 2018 Jun; 33(5):348-349. PubMed ID: 28535923
[No Abstract] [Full Text] [Related]
24. BASAL CELL CARCINOMA AND SQUAMOUS CELL CARCINOMA IN A PATIENT TREATED WITH FINGOLIMOD FOR MULTIPLE SCLEROSIS - A CASE REPORT AND LITERATURE REVIEW.
Zięba N; Gębka-Kępińska B; Sowa P
Wiad Lek; 2022; 75(3):735-741. PubMed ID: 35522887
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C during disease modifying therapy with Fingolimod for Relapsing Remitting Multiple Sclerosis: diagnosis and treatment.
Aslanyan A; Anwar-Hashim Z; Siripurapu R; Mihalova T
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33637491
[TBL] [Abstract][Full Text] [Related]
26. Mycosis fungoides - A cutaneous lymphoproliferative disorder in a patient treated with fingolimod for multiple sclerosis.
Nitsan Z; Kucuk N; Appel S; Tichmanovich N; Osherov M; Milo R
J Clin Neurosci; 2018 Feb; 48():102-103. PubMed ID: 29108666
[TBL] [Abstract][Full Text] [Related]
27. Fingolimod-related atrioventricular block in paediatric age group with multiple sclerosis: two case reports.
Kum YE; Pamukçu Ö; Canpolat M
Cardiol Young; 2023 Nov; 33(11):2384-2386. PubMed ID: 37170775
[TBL] [Abstract][Full Text] [Related]
28. Asymptomatic bradycardia after first fingolimod dose in a pediatric patient with multiple sclerosis - a case report.
Petruzzo M; Lanzillo R
Neurol Sci; 2021 May; 42(Suppl 1):37-39. PubMed ID: 33635428
[TBL] [Abstract][Full Text] [Related]
29. Retinal hemorrhages following fingolimod treatment for multiple sclerosis; a case report.
Ueda N; Saida K
BMC Ophthalmol; 2015 Oct; 15():135. PubMed ID: 26481728
[TBL] [Abstract][Full Text] [Related]
30. Ventricular tachycardia after initiation of fingolimod.
Elounais F; Aburahma A; Alkotob ML; Al Hadidi S
BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28954755
[TBL] [Abstract][Full Text] [Related]
31. Fingolimod-associated macular oedema.
Jasani KM; Sharaf N; Rog D; Aslam T
BMJ Case Rep; 2017 Jun; 2017():. PubMed ID: 28619738
[No Abstract] [Full Text] [Related]
32. Ventricular arrhythmia in a male MS patient on fingolimod.
van Pesch V; Marchandise S; El Sankari S; Sindic C
Acta Neurol Belg; 2015 Mar; 115(1):77-9. PubMed ID: 24710722
[No Abstract] [Full Text] [Related]
33. A case of dextrocardia following maternal exposure to generic Fingolimod during the first trimester of pregnancy.
Navardi S; Sahraian MA
Mult Scler Relat Disord; 2018 Apr; 21():69-70. PubMed ID: 29474980
[TBL] [Abstract][Full Text] [Related]
34. Disease reactivation after fingolimod cessation in Multiple Sclerosis patients with pregnancy desire: A retrospective study.
Callens A; Leblanc S; Le Page E; Edan G; Jourdain A; Coustans M; Wiertlewski S; Laplaud D; Videt D; Lallement F; Leray E; Michel L
Mult Scler Relat Disord; 2022 Oct; 66():104066. PubMed ID: 35908450
[TBL] [Abstract][Full Text] [Related]
35. Cryptococcal Meningoencephalitis in a Patient With Multiple Sclerosis Treated With Fingolimod.
Achtnichts L; Obreja O; Conen A; Fux CA; Nedeltchev K
JAMA Neurol; 2015 Oct; 72(10):1203-5. PubMed ID: 26457631
[No Abstract] [Full Text] [Related]
36. Reversible cerebral vasoconstriction syndrome associated with fingolimod treatment in relapsing-remitting multiple sclerosis three months after childbirth.
Kraemer M; Weber R; Herold M; Berlit P
Mult Scler; 2015 Oct; 21(11):1473-5. PubMed ID: 26283695
[TBL] [Abstract][Full Text] [Related]
37. Necrotizing fungal osteomyelitis and fingolimod, 4 years after treatment with fingolimod.
Harirchian MH; Poursadeghfard M; Sadeghipour A; Kamali H; Sarraf P
Mult Scler Relat Disord; 2020 Jun; 41():102021. PubMed ID: 32126512
[TBL] [Abstract][Full Text] [Related]
38. Early and recurrent macular oedema in a patient treated with fingolimod.
Cifuentes-Canorea P; Nieves-Moreno M; Sáenz-Francés F; Santos-Bueso E
Neurologia (Engl Ed); 2019 Apr; 34(3):206-207. PubMed ID: 27776961
[No Abstract] [Full Text] [Related]
39. A tumefactive demyelinating lesion in a person with MS after five years of fingolimod.
Jeung L; Smits LMG; Hoogervorst ELJ; van Oosten BW; Frequin STFM
Mult Scler Relat Disord; 2020 May; 40():101978. PubMed ID: 32062445
[TBL] [Abstract][Full Text] [Related]
40. Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis.
Izquierdo G; O'Connor P; Montalban X; von Rosenstiel P; Cremer M; de Vera A; Sfikas N; Francis G; Radue EW; Kappos L
Mult Scler; 2014 Jun; 20(7):877-81. PubMed ID: 24293455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
